Supplement
Paraxanthine clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2021
How studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
3 studies that test it; most in 2021 (1)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 1
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Texas Tech University Health Sciences Center (1) · Lindenwood University (1) · Iovate Health Sciences International Inc (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses paraxanthine is read from its arms, and is right about nine times in ten.
Testing it · 3
- L-theanine and Paraxanthine for Cognitive Improvement in Adults With ADHD and ASDCompletedNot applicableTexas Tech University Health Sciences CenterNCT07189442Written as L-theanine and paraxanthine
- Effects of Paraxanthine Supplementation on eSport PerformancreCompletedNot applicableLindenwood UniversityNCT07533045Written as Paraxanthine
- Acute Effects of Paraxanthine on Energy and FocusCompletedPhase 1/2Iovate Health Sciences International IncNCT06628596Written as Paraxanthine 200mg and 300mg
Codes
What other systems call paraxanthine · ClinicalTrials.gg INT002742
- MeSH (NLM) C0211831,7-dimethylxanthineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) Q3565Y41V7PARAXANTHINEConfirmed NLM, Wikidata
- Wikidata Q419223paraxanthineConfirmed NLM, Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C021183 | 1,7-dimethylxanthine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | Q3565Y41V7 | PARAXANTHINE | Confirmed NLM, Wikidata |
| Wikidata | Q419223 | paraxanthine | Confirmed NLM, Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.